Home > Healthcare > Medical Devices > Medical Supplies > Biosensors Market

Biosensors Market Size

  • Report ID: GMI747
  • Published Date: Oct 2024
  • Report Format: PDF

Biosensors Market Size

The global biosensors market size was valued at around USD 30.1 billion in 2023 and is estimated to grow at 7.7% CAGR from 2024 to 2032. The growing prevalence of diabetes worldwide is the primary factor driving the expansion of the business.

 

Effective management and control of diabetes are essential to avoid complications such as kidney failure, gangrene, lower limb amputation, heart attack, blindness, and stroke. According to data provided by the World Health Organization (WHO), the prevalence of diabetes has been rising rapidly in low- and middle-income countries compared to high-income countries as of 2021. Rapid urbanization has led to sedentary lifestyles, unhealthy diets, and higher stress levels among youth, which are contributing factors for diabetes and, consequently.
 

Biosensors are analytical devices within medical and diagnostic systems that convert biological signals into measurable outputs. They consist of a biological recognition element, such as enzymes or antibodies, which interacts with a specific analyte, and a transducer that translates this interaction into a quantifiable signal. This technology facilitates rapid, sensitive, and precise detection of various health-related biomarkers, supporting early disease diagnosis and effective monitoring.
 

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

The global biosensors industry was valued at approximately USD 30.1 billion in 2023 and is estimated to grow at a 7.7% CAGR from 2024 to 2032, driven by the rising global prevalence of diabetes.

The non-wearable biosensors segment held a substantial 64.2% market share in 2023 due to their ease of use, high accuracy, and rapid diagnostic capabilities.

The point-of-care testing (POC) segment is projected to reach USD 29.8 billion by 2032, as biosensors in POC testing provide quick results, crucial for acute conditions and emergencies.

Key players in the industry include Abbott Laboratories, Ascensia Diabetes Care Holdings, Bio-Rad Laboratories, Biosensors International Group, Danaher Corporation, Dexcom, F. Hoffmann-La Roche, LifeScan, Masimo, and Nova Biomedical.

Biosensors Market Scope

Buy Now

Immediate Delivery Available

Premium Report Details

  • Base Year: 2023
  • Companies covered: 15
  • Tables & Figures: 240
  • Countries covered: 18
  • Pages: 215
 Download Free Sample